Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edotecarin in Anthracycline- and Taxane-Resistant Metastatic Breast Cancer
NCT00067314Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jun 2003
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of edotecarin in breast cancer, sponsored by Pfizer. Started Jun 2003; status: completed.
02
Drugs
edotecarin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00067314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067314.